Tovar GVJ, Ortiz CF, Jiménez GFR, Valencia VG

Language: Spanish
References: 6
Page: 47-51
PDF size: 98.73 Kb.

ABSTRACT

Cervical cancer is one of the principal causes of death of women and occurs in some 231,000 cases per year in the world, and 80% of cases in developing countries. The incidence of the year 2000 was of 466,000 cases and 95 to 99% of the cases are related with papilloma of the groups 16 and 18 which are considered carcinogenetics. In Mexico there was a total of 48,761 of defunctions with a mean of 12 women every year and a yearly increment of 0.76%. The state in which predominated was Colima and Nayarit and they studied the cause and year of presentation, as well as the potential life lost using the life-expectancy of 74 years and the calculation was of periods of five years.

REFERENCES

1. Sankaranarayanan R, Madhukar Budukh A, Rajkumar R. Effective screening programmers for cervical cancer in low- and middle-income developing countries. Bulletin of the World Health Organization 2001; 79: 954-62.

2. Manji M. Cervical cancer screening program in Saudi Arabia: Action is overdue. Annals of Saudi Medicine 2000; 20(5-6): 355-57.

3. Jung W, Chun T, Sul D, Woo Hwang K, Kang H, Joo Lee D, Han I. Strategies against human papillomavirus infection and cervical cancer. The Journal of Microbiology 2004; 42(4): 255-66.

4. Serman F. Cáncer cervicouterino: Epidemiología, historia natural y rol del virus del papiloma humano. Perspectivas en prevención y tratamiento. Rev Chil Obstet Ginecol 2002; 67(4): 318-323.

5. Coleman M et al. Time trends in cancer incidence and mortality. Lyon, International Agency for Research on Cancer, 1995 (IARC Scientific Publications No. 121).

6. Palacio-Mejía LS, Rangel-Gómez G, Hernández-Ávila M, Lazcano-Ponce E. Cervical cancer, a disease of poverty: Mortality differences between urban and rural areas in Mexico. Salud Pública Mex 2003; 45 supl: S315-S325.